Literature DB >> 25669199

Factoring in Factor VIII With Acute Ischemic Stroke.

James E Siegler1, Alyana Samai2, Karen C Albright3, Amelia K Boehme4, Sheryl Martin-Schild5.   

Abstract

There is growing research interest into the etiologies of cryptogenic stroke, in particular as it relates to hypercoagulable states. An elevation in serum levels of the procoagulant factor VIII is recognized as one such culprit of occult cerebral infarctions. It is the objective of the present review to summarize the molecular role of factor VIII in thrombogenesis and its clinical use in the diagnosis and prognosis of acute ischemic stroke. We also discuss the utility of screening for serum factor VIII levels among patients at risk for, or those who have experienced, ischemic stroke.
© The Author(s) 2015.

Entities:  

Keywords:  factor viii; hypercoagulability; stroke; thrombosis; von Willebrand factor

Mesh：

Substances：

Year:  2015        PMID： 25669199      PMCID： PMC4948295          DOI： 10.1177/1076029615571630

Source DB:  PubMed          Journal:  Clin Appl Thromb Hemost        ISSN： 1076-0296            Impact factor:   2.389


  48 in total

1.  Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII.

Authors:  Carine J M Doggen; Frits R Rosendaal; Joost C M Meijers
Journal:  Blood       Date:  2006-08-24       Impact factor: 22.113

2.  Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium.

Authors:  K S Sakariassen; P A Bolhuis; J J Sixma
Journal:  Nature       Date:  1979-06-14       Impact factor: 49.962

3.  Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions.

Authors:  P W Kamphuisen; J C Eikenboom; H L Vos; R Pablo; A Sturk; R M Bertina; F R Rosendaal
Journal:  Thromb Haemost       Date:  1999-05       Impact factor: 5.249

4.  Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study.

Authors:  Ann Smith; Chris Patterson; John Yarnell; Ann Rumley; Yoav Ben-Shlomo; Gordon Lowe
Journal:  Circulation       Date:  2005-11-15       Impact factor: 29.690

5.  Associations between carotid atherosclerosis and high factor VIII activity, dyslipidemia, and hypertension.

Authors:  W H Pan; C H Bai; J R Chen; H C Chiu
Journal:  Stroke       Date:  1997-01       Impact factor: 7.914

6.  Arterial disease risk factors and angiographic evidence of atheroma of the carotid artery.

Authors:  A Schneidau; M J Harrison; C Hurst; H C Wilkes; T W Meade
Journal:  Stroke       Date:  1989-11       Impact factor: 7.914

7.  Factor VIII in the setting of acute ischemic stroke among patients with suspected hypercoagulable state.

Authors:  Tiffany R Chang; Karen C Albright; Amelia K Boehme; Adrianne Dorsey; E Alton Sartor; Rebecca Kruse-Jarres; Cindy Leissinger; Sheryl Martin-Schild
Journal:  Clin Appl Thromb Hemost       Date:  2013-05-14       Impact factor: 2.389

8.  Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.

Authors:  A Hamsten; U de Faire; G Walldius; G Dahlén; A Szamosi; C Landou; M Blombäck; B Wiman
Journal:  Lancet       Date:  1987-07-04       Impact factor: 79.321

9.  Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale.

Authors:  Vesa Karttunen; Leena Hiltunen; Vesa Rasi; Elina Vahtera; Matti Hillbom
Journal:  Blood Coagul Fibrinolysis       Date:  2003-04       Impact factor: 1.276

10.  Vitamin E suppresses enhancement of factor VIII-dependent thrombin generation by systemic hypoxia.

Authors:  Jong-Shyan Wang; Mei-Ling Cheng; Hsiu-Chuan Yen; Bih-Show Lou; Huang-Chun Liu
Journal:  Stroke       Date:  2008-10-23       Impact factor: 7.914
View more
  9 in total

1.  Paroxysmal atrial fibrillation: changes in factor VIII and von Willebrand factor impose early hypercoagulability.

Authors:  Mariya Negrinova Negreva; Krasimira Prodanova; Katerina Vitlianova; Christiana Madjova
Journal:  Arch Med Sci Atheroscler Dis       Date:  2020-07-11

2.  Effect of PCSK9 Inhibitors on Hemostasis in Patients with Isolated Hypercholesterolemia.

Authors:  Marcin Basiak; Marcin Hachula; Michal Kosowski; Boguslaw Okopien
Journal:  J Clin Med       Date:  2022-05-01       Impact factor: 4.964

3.  Rare case of simultaneous cerebral artery and venous sinus thrombosis in the setting of elevated factor VIII and combined oral contraceptive pills.

Authors:  Abeer Sabry Safan; Omnia A Hamid; Abdulrahman Al-Mashdali; Arwa AlSaud; Shaikha Al-Shokri; Abdelrahman Hamad
Journal:  Clin Case Rep       Date:  2022-03-15

Review 4.  Sex differences in predictors of ischemic stroke: current perspectives.

Authors:  Alyana A Samai; Sheryl Martin-Schild
Journal:  Vasc Health Risk Manag       Date:  2015-07-27

5.  Elevated Factor VIII and von Willebrand Factor Levels Predict Unfavorable Outcome in Stroke Patients Treated with Intravenous Thrombolysis.

Authors:  Noémi Klára Tóth; Edina Gabriella Székely; Katalin Réka Czuriga-Kovács; Ferenc Sarkady; Orsolya Nagy; Levente István Lánczi; Ervin Berényi; Klára Fekete; István Fekete; László Csiba; Zsuzsa Bagoly
Journal:  Front Neurol       Date:  2018-01-23       Impact factor: 4.003

6.  Coagulation factor VIII, white matter hyperintensities and cognitive function: Results from the Cardiovascular Health Study.

Authors:  Jessica L Rohmann; W T Longstreth; Mary Cushman; Annette L Fitzpatrick; Susan R Heckbert; Kenneth Rice; Frits R Rosendaal; Colleen M Sitlani; Bruce M Psaty; Bob Siegerink
Journal:  PLoS One       Date:  2020-11-16       Impact factor: 3.240

Review 7.  Pleiotropic Effects of PCSK-9 Inhibitors.

Authors:  Marcin Basiak; Michał Kosowski; Marcin Cyrnek; Łukasz Bułdak; Mateusz Maligłówka; Grzegorz Machnik; Bogusław Okopień
Journal:  Int J Mol Sci       Date:  2021-03-19       Impact factor: 5.923

Review 8.  Osteonecrosis of the Jaws in Patients with Hereditary Thrombophilia/Hypofibrinolysis-From Pathophysiology to Therapeutic Implications.

Authors:  Minerva Codruta Badescu; Elena Rezus; Manuela Ciocoiu; Oana Viola Badulescu; Lacramioara Ionela Butnariu; Diana Popescu; Ioana Bratoiu; Ciprian Rezus
Journal:  Int J Mol Sci       Date:  2022-01-07       Impact factor: 5.923

Review 9.  Insight into the Evolving Role of PCSK9.

Authors:  Mateusz Maligłówka; Michał Kosowski; Marcin Hachuła; Marcin Cyrnek; Łukasz Bułdak; Marcin Basiak; Aleksandra Bołdys; Grzegorz Machnik; Rafał Jakub Bułdak; Bogusław Okopień
Journal:  Metabolites       Date:  2022-03-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.